Drugs / Fluticasone/Salmeterol
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02491970 Comparator | Aug 2015 → Apr 2017 | asthma | Mundipharma Korea Ltd | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluticasone/Salmeterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02491970 ↗ |
| Route | Inhaled | “Mode of administration: oral inhalation” NCT02491970 ↗ |